Foodie Pundit

The End of "More is More"? Why The FDA Is Quietly Rewriting The Rules on Your Supplements

A major FDA policy shift, Project Optimus, is moving away from mega-doses to "optimal" doses. Discover how this will impact your supplements, food, and prices.

By Foodie Pundit Newsroom - Published - Updated - Section: Policy Regulation

The End of "More is More"? Why The FDA Is Quietly Rewriting The Rules on Your Supplements

Key points

  • The FDA's "Project Optimus" is shifting focus from "maximum tolerated dose" to "optimal biological dose," a change poised to disrupt the supplement and functional food industries.
  • The "more is more" marketing strategy of mega-dosing vitamins and nutrients is being challenged, forcing brands to invest in R&D to prove their recommended serving sizes are truly optimal, not just high.
  • This regulatory shift could cause major disruptions in the ingredient supply chain, decreasing demand for bulk commodities while increasing value for patented, highly bioavailable ingredients.
  • Consumers will be empowered to choose products based on scientific precision rather than inflated marketing claims, leading to a safer and more effective wellness market.

This report is part of Foodie Pundit premium coverage. Foodie Pundit members read the full story. See membership.

Sources and methodology

Reported from primary records. Open any source to verify a claim.

All sources Foodie Pundit reports from

More from the Foodie Pundit Newsroom

Permalink